Vanguard Fiduciary Trust
DAWN

Vanguard Fiduciary Trust’s Day One Biopharmaceuticals DAWN Stock Holding History

Vanguard Fiduciary Trust’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-478,839
Closed -$10.3M – 4094
2026
Q1 		$10.3M Buy
+478,839
New +$6.75M ﹤0.01% 1699

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Fiduciary Trust's DAWN Position: Q2 2026 in Review

Vanguard Fiduciary Trust sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 478,839 shares — an estimated $10.3M sold.

Vanguard Fiduciary Trust first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $10.3M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Vanguard Fiduciary Trust reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Vanguard Fiduciary Trust sold 478,839 Day One Biopharmaceuticals shares in Q2 2026, an estimated $10.3M.
  • Vanguard Fiduciary Trust first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Vanguard Fiduciary Trust's Day One Biopharmaceuticals position peaked at $10.3M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.